Tags

, , , , , , , , , , , , , , , , , , , ,


Hip Study: Smith & Nephew touts study results for new metal-on-metal implants | MassDevice – Medical Device Industry News.

Hip Study: Smith & Nephew touts study results for new metal-on-metal implants

March 13, 2012 by MassDevice staff

Smith & Nephew unveils the results of its FDA-requested metal-on-metal hip resurfacing implant study, finding that 99% of participants were either satisfied or extremely satisfied with their implants at 10 years.

British orthopedic titan Smith & Nephew (NYSE:SNN) touted the results of a 10-year study of its metal-on-metal hip resurfacing implants, hoping to differentiate its implants from the high-profile recall of rival DePuy‘s ASR device.

Smith & Nephew, one of the largest metal-on-metal hip implant makers, is looking to limit the collateral damage to its Birmingham hip resurfacing system from the Johnson & Johnson (NYSE:JNJ) subsidiary’s ASR recall. J&J is facing down a slew of patient injury lawsuits, not to mention scientists warning of possible toxicity and bone destruction related to the implants and researchers urging the FDA to ban the devices entirely.

Smith & Nephew’s latest data, from a study it ran at the request of the FDA, found that 99% of the U.K. 400 patients followed were either satisfied or extremely satisfied with their Birmingham hip after 10 years, according to a press release.

About these ads